ATC Group: M01AX Other antiinflammatory and antirheumatic agents, non-steroids

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of M01AX in the ATC hierarchy

Level Code Title
1 M Musculo-skeletal system
2 M01 Antiinflammatory and antirheumatic products
3 M01A Antiinflammatory and antirheumatic products, non-steroids
4 M01AX Other antiinflammatory and antirheumatic agents, non-steroids

Group M01AX contents

Code Title
M01AX01 Nabumetone
M01AX02 Niflumic acid
M01AX04 Azapropazone
M01AX05 Glucosamine
M01AX07 Benzydamine
M01AX12 Glucosaminoglycan polysulfate
M01AX13 Proquazone
M01AX14 Orgotein
M01AX17 Nimesulide
M01AX18 Feprazone
M01AX21 Diacerein
M01AX22 Morniflumate
M01AX23 Tenidap
M01AX24 Oxaceprol
M01AX25 Chondroitin sulfate
M01AX26
M01AX68 Feprazone, combinations

Active ingredients in M01AX

Active Ingredient Description
Benzydamine

Benzydamine exerts an anti-inflammatory and analgesic action by stabilising the cellular membrane and inhibiting prostaglandin synthesis.

Chondroitin sulfate

Chondroitin sulfate belongs to the polysaccharide subgroup of glycosaminoglycans. Chondroitin sulfate is one of the main elements of the cartilage, which joins a central protein, forming what we know as proteoglycan, which is what gives the cartilage its mechanical and elastic properties.

Diacerein

Diacerein is an anthraquinone derivative which has moderate anti-inflammatory activity. It is anti-inflammatory at high doses and devoid of any irritant effect on the stomach.

Glucosamine

Glucosamine is an endogenous substance, a normal constituent of the polysaccharide chains of cartilage matrix and synovial fluid glucosaminoglycans. In vitro and in vivo studies have shown glucosamine stimulates the synthesis of physiological glycosaminoglycans and proteoglycans by chondrocytes and of hyaluronic acid by synoviocytes.

Nabumetone

Nabumetone is a non acidic non steroidal anti-inflammatory agent with weak prostaglandin synthesis properties. Nabumetone undergoes rapid and extensive metabolism in the liver to 6-methoxy-2-naphthylacetic acid (6-MNA), the principal active metabolite which is a potent inhibitor of prostaglandin synthesis.

Niflumic acid

Niflumic acid is an analgesic and anti-inflammatory agent used in the treatment of rheumatoid arthritis.

Nimesulide

Nimesulide is a non-steroidal anti-inflammatory drug with analgesic and antipyretic properties which acts as an inhibitor of prostaglandin synthesis enzyme cyclo-oxygenase. Cyclo-oxygenase produces prostaglandins, some of them being implicated in the development and maintenance of inflammation.

Oxaceprol
Soybean oil, refined

Related product monographs

Title Information Source Document Type  
APONIL Tablet Υπουργείο Υγείας (CY) MPI, EU: SmPC
AULIN Gel Health Products Regulatory Authority (IE) MPI, EU: SmPC
CHONDROMEL Hard capsule Health Products Regulatory Authority (IE) MPI, EU: SmPC
DIFFLAM Lozenge Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
DOLENIO Film-coated tablets Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
MESULID Tablet MPI, EU: SmPC
NIMM Tablet Υπουργείο Υγείας (CY) MPI, EU: SmPC
RELAFEN Tablet FDA, National Drug Code (US) MPI, US: SPL/Old